Clinical safety research and considerations of human respiratory syncytial virus vaccine
LIU Lin-yu
LU Shuang
Abstract：Human respiratory syncytial virus(RSV)is a common pathogen that causes lower respiratory tract infections.At present,symptomatic and supportive treatment remains the main treatment for RSV infections,while vaccination is one of the effective means to prevent such infections.Infants,the elderly and other immunocompromised people are at high risk of RSV infection.Therefore,it is important to pay attention to the safety evaluation of RSV vaccine in clinical research.This paper will discuss the safety evaluation of RSV vaccines alongside the clinical safety researches of RSV vaccines approved abroad.
Keywords：human respiratory syncytial virusvaccinesafety researchsafety evaluation
Publication Date：2025-04-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 693-698 )